The Vaccine Trust Problem
Public health officials and private researchers have vowed to develop a coronavirus vaccine in record time. But could that rush backfire? Guest: Jan Hoffman, a health reporter for The New York Times. For more information on today’s episode, visit nytimes.com/thedaily Background reading: Billions of dollars are being poured into developing a coronavirus vaccine, but the rapid timetable may be creating even more vaccine-hesitant patients.Three vaccine developers report that early trials showed promising results with minimal side effects, but one researcher cautioned, “There is still a long way to go.”
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Public health officials and private researchers have vowed to develop a coronavirus vaccine in record time. But could that rush backfire? Guest: Jan Hoffman, a health reporter for The New York Times. For more information on today’s episode, visit nytimes.com/thedaily
Background reading:
- Billions of dollars are being poured into developing a coronavirus vaccine, but the rapid timetable may be creating even more vaccine-hesitant patients.
- Three vaccine developers report that early trials showed promising results with minimal side effects, but one researcher cautioned, “There is still a long way to go.”
Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.